<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01963819</url>
  </required_header>
  <id_info>
    <org_study_id>Miacol-2013-1H</org_study_id>
    <nct_id>NCT01963819</nct_id>
  </id_info>
  <brief_title>Therapeutic Endometrial Biopsy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the potential benefits in implantation, clinical
      pregnancy and live birth rates by an endometrial biopsy prior to an IVF/ICSI treatment.
      Including a follow up on possible pregnancy complications and data on children at birth.

      Further it is planned to aspirate secretions from the uterus and take blood samples during
      the treatment, which presumably can provide information about the mechanisms underlying the
      possible effect of the treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized controlled prospective clinical study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of clinical pregnancy</measure>
    <time_frame>Individual outcome will be evaluated within 8 weekes after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of biochemical pregnancy</measure>
    <time_frame>Individual outcome will be evaluated within 8 weeks after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of implantation</measure>
    <time_frame>Individual outcome will be evaluated within 8 weekes after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of live birth</measure>
    <time_frame>Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of pregnancy complications</measure>
    <time_frame>Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
    <description>Placenta abnormalities, pregnancy related hypetensive disorders, IUGR, GDM</description>
  </other_outcome>
  <other_outcome>
    <measure>Data on children and placenta at birth</measure>
    <time_frame>Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
    <description>Gestationel age, Preterm birth, LGA/SGA/NGA, Gender, Placenta abnormalities</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Infertility</condition>
  <condition>Endometrium</condition>
  <condition>ART</condition>
  <condition>Endometrial Biopsy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endometrial biopsy before standard treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endometrial biopsy</intervention_name>
    <description>The endometrial biopsy will be done in the luteal phase (cycle day 18-22) prior to the treatment cycle (antagonist)</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Endometrial scratching</other_name>
    <other_name>Endometrial injury</other_name>
    <other_name>Local injury to the endometrium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  One or more previous failed implantation despite transfer of good quality
             embryons/blastocyst in a fresh IVF/ICSI treatment

          -  Planned Antagonist treatment

          -  Planned Standardized hormone treatment

          -  FSH: 2-12 IU/L

          -  Age: 18-40 years

          -  BMI: 18-32

          -  Regular menstrual cycles

          -  Written consent

        Exclusion Criteria:

          -  Patients in need for a interpreter

          -  Suspected intrauterine abnormalities ( fibromes, polyps, adenomyosis, sactosalpinges)

          -  Planned use og Assisted hatching or use of specialized media

          -  Previous inclusion in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Forman, MD, DMsc</last_name>
    <role>Study Director</role>
    <affiliation>Departement of Gynaecology and Obstetrics, Aarhus University Hospital, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Inge E Agerholm, M.Sc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic, Horsens Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benedicte Hauge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic, Horsens Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Humaidan, MD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic, Skive Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mia Steengaard Olesen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic Horsens Hospital, Aarhus University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mia Steengaard Olesen, MD</last_name>
    <phone>+4578426562</phone>
    <email>miaolsen@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Axel Forman, MD, DMsc</last_name>
    <email>axel.forman@ki.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fertility Clinic, Dronninglund Hospital (Aalborg University Hospital)</name>
      <address>
        <city>Dronninglund</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fertility Clinic, Horsens Hospital</name>
      <address>
        <city>Horsens</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mia Steengaard Olesen, MD</last_name>
      <email>miaolsen@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fertility Clinic, Skive Hospital</name>
      <address>
        <city>Skive</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2013</study_first_submitted>
  <study_first_submitted_qc>October 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2013</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

